Novel system to get dying patients an experimental cancer drug raises hopes — and thorny questions https://www.statnews.com/2016/11/08/cancer-drug-compassionate-use/ Janssen’s parent company, Johnson & Johnson, decided on a unique approach: Rather than try to deal with the barrage of requests itself, it asked a leading bioethicist to create an independent committee to determine which desperate patients could get access to the limited supplies of its experimental drug, known as daratumumab.